Acutaas Chemicals Limited (ACUTAAS) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

CompoundingAI Research Updated July 20, 2026 3 min read

Acutaas Chemicals Limited enters its Q1 FY 2026-2027 results following a period of aggressive capacity expansion and strong sequential revenue growth throughout the last fiscal year. Investors will be looking for updates on the commissioning timeline for new projects and whether the company can maintain its recent margin trajectory amid a stabilising bulk chemicals pricing environment.

Quick Details

Results date	July 24, 2026
Quarter	Q1 FY 2026-2027
Previous quarter revenue	Rs. 432.75 Cr
Previous quarter PAT	Rs. 131.76 Cr
Market cap	Rs. 29,917.37 Cr
CMP	Rs. 3,654.2

Acutaas Chemicals Limited Q1 Results Date and Time

Acutaas Chemicals Limited will hold its board meeting on July 24, 2026, to consider the audited financial results.

What to expect from Acutaas Chemicals Limited's Q1 FY27 results

The company's revenue trajectory showed strong momentum throughout FY2025-26, rising from Rs. 207 Cr in Q1 to Rs. 432.75 Cr by Q4. While the bulk chemicals pricing environment has entered a consolidation phase, the company's strong Q4 exit run-rate suggests underlying demand remains intact. Margins may face slight pressure from increased depreciation as the company capitalises its Rs. 332.3 Cr of capital work-in-progress, following a total FY2025-26 capex spend of Rs. 328.0 Cr. Management's commentary on the sustainability of the current revenue run-rate and the progress of new capacity commissioning will be critical for assessing the growth outlook in the coming quarters.

Key Things To Watch

Capacity Expansion and Capex: The company is in a significant investment phase to support volume growth.

Capital work-in-progress stood at Rs. 332.3 Cr as of March 31, 2026, indicating significant ongoing capacity ramp-up.
FY2025-26 total capex reached Rs. 328.0 Cr, supported by cash from operations of Rs. 292.2 Cr.

Working Capital Dynamics: Management's management of receivables and inventory is a key operational focus.

Trade receivables were elevated at Rs. 362.6 Cr, representing approximately 0.84x of Q4 revenue.
Monitoring of inventory levels, which stood at Rs. 231.3 Cr at the end of the previous quarter.

Operating Metric Trajectory: Pricing and volume trends in the bulk chemicals segment.

Caustic soda prices settled into a consolidation phase by the end of June 2026 after earlier downward corrections.
Evaluation of whether sequential revenue growth continued from the Q4 run-rate of Rs. 432.75 Cr.

Frequently Asked Questions

What was the company's revenue in the previous quarter?

Acutaas Chemicals Limited reported revenue of Rs. 432.75 Cr in Q4 FY2025-26. This figure represented sequential growth from the Rs. 393 Cr reported in Q3.

How did the company's profitability change in the last quarter?

The company reported a PAT of Rs. 131.76 Cr in Q4 FY2025-26. This reflected strong margin expansion compared to the Rs. 62.5 Cr reported in Q4 FY2024-25.

What is the status of the company's debt position?

The company maintained a strong balance sheet with net cash of approximately Rs. 189 Cr as of the end of Q4 FY2025-26. This position consisted of Rs. 215.5 Cr in cash against total borrowings of Rs. 26.5 Cr.